News from REMEDY

During Arendal Week, some of Norway's most influential voices in health policy will gather for a hotly debate: How can patient apps with documented effects actually be used in the health service? Experience the event online or in person in Arendal! Here's the background for the debate: 

The Department of Rheumatology, Outpatient Clinic and Research and the REMEDY Research Center organized the Green Congress for Rheumatology on June 20. The event offered highlights from EULAR 2025 in a climate-friendly setting.

Chronicle in Dagens Medisin by Ingvild Kjeken, senior researcher at Diakonhjemmet Hospital and professor of occupational therapy at OsloMet and Kari-Jussie Lønning, hospital director, Diakonhjemmet Hospital. 

To strengthen research collaboration between the institutions in the Diakonhjemmet family, a total of NOK 200,000 in seed funding is being announced. Diakonhjemmet Hospital, VID University College of Science, Diakonova Vocational School and Diakonhjemmet Care are included in the scheme.

On May 7-9, 2025, the graduate school course User Participation in Medical and Health Research was conducted at the Eitri Medical Incubator Center for the 4th time. 

These diseases have long been considered a risk factor for more serious heart attacks. Now, researchers have investigated how these patients actually fare – and the findings challenge what many have believed.

The usability study provided good reasons to continue research on the Urika app. Now the randomized controlled trial on digital follow-up of gout is underway.

Brun has researched personalized treatment. Could her research be the solution for patients who don't benefit as much from medications as others?